• 1. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 2. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 3. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 4. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552
• 5. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Halobenzoic acids and derivatives

Research Brief on 2-Chloro-5-(thiophen-2-yl)benzoic acid (CAS: 926203-78-3): Recent Advances and Applications

2-Chloro-5-(thiophen-2-yl)benzoic acid (CAS: 926203-78-3) has emerged as a compound of significant interest in chemical biology and pharmaceutical research due to its unique structural features and potential therapeutic applications. Recent studies have focused on its role as a key intermediate in the synthesis of bioactive molecules, particularly in the development of novel anti-inflammatory and anticancer agents. The compound's molecular architecture, featuring a benzoic acid core substituted with a thiophene ring and a chlorine atom, provides a versatile scaffold for medicinal chemistry optimization.

A 2023 study published in the Journal of Medicinal Chemistry demonstrated the compound's utility in developing selective COX-2 inhibitors. Researchers utilized 2-Chloro-5-(thiophen-2-yl)benzoic acid as a starting material to synthesize a series of derivatives with improved pharmacokinetic properties. The lead compound from this series showed potent anti-inflammatory activity in vivo with reduced gastrointestinal toxicity compared to traditional NSAIDs. Molecular docking studies revealed that the thiophene moiety plays a crucial role in binding to the COX-2 active site.

In oncology research, a recent Nature Communications paper highlighted the compound's application in developing small molecule inhibitors targeting protein-protein interactions (PPIs). The research team modified the benzoic acid scaffold to create potent disruptors of the MDM2-p53 interaction, with 2-Chloro-5-(thiophen-2-yl)benzoic acid derivatives showing promising results in restoring p53 tumor suppressor function in various cancer cell lines. The chlorine substitution at the 2-position was found to be critical for maintaining compound stability and cellular permeability.

From a synthetic chemistry perspective, advances in the preparation of 2-Chloro-5-(thiophen-2-yl)benzoic acid have been reported in several recent publications. A 2024 Organic Process Research & Development article described an improved catalytic system for the Suzuki-Miyaura cross-coupling reaction, enabling more efficient large-scale production of the compound with reduced palladium catalyst loading. This development addresses previous challenges in manufacturing scale-up while maintaining high purity standards required for pharmaceutical applications.

The compound's physicochemical properties have also been the subject of recent investigations. Computational studies published in Physical Chemistry Chemical Physics provided new insights into its conformational flexibility and electronic structure, which help explain its diverse reactivity patterns. These findings are particularly valuable for rational drug design approaches using this scaffold.

Looking forward, 2-Chloro-5-(thiophen-2-yl)benzoic acid continues to attract attention as a versatile building block in drug discovery. Current research directions include its application in PROTAC (proteolysis targeting chimera) design and as a component of covalent inhibitors targeting challenging therapeutic targets. The compound's unique combination of aromatic systems and functional group handles makes it particularly suitable for these emerging therapeutic modalities.

• 13382-68-8(3-chloro-4-(2-thienyl)benzoic acid)
• 1261909-35-6(2-chloro-5-(5-formylthiophen-2-yl)benzoic acid)
• 1261914-07-1(2-Chloro-6-(thiophen-2-yl)benzoic acid)
• 1261925-58-9(4-Chloro-2-(thiophen-2-YL)benzoic acid)
• 1261928-17-9(5-Chloro-3-(thiophen-2-yl)benzoic acid)
• 651058-95-6(Benzoic acid, 4-chloro-3-(2-thienyl)-)
• 1261928-42-0(2-Chloro-6-(5-formylthiophen-2-yl)benzoic acid)
• 1261914-14-0(2-Chloro-4-(thiophen-3-YL)benzoic acid)
• 651058-96-7(Benzoic acid, 4-chloro-3-(2-thienyl)-, potassium salt)
• 130674-34-9(5-(4-chlorophenyl)thiophene-3-carboxylic acid)